| Lizenz: Creative Commons Namensnennung-NichtKommerziell-KeineBearbeitung 4.0 International PDF - Veröffentlichte Version Early View (1MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-492510
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.49251
Zusammenfassung
Background Extracorporeal photopheresis (ECP), an apheresis-based therapy for various immunological diseases, works mainly by inducing apoptosis in lymphocytes. Several factors influence the efficacy of ECP with the photosensitizer 8-methoxypsoralen (8-MOP) and ultraviolet light A (UVA). This study aimed to optimize treatment by varying the 8-MOP starting concentration and the cell suspension ...
![plus plus](/style/images/plus.png)
Nur für Besitzer und Autoren: Kontrollseite des Eintrags